| A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies (NCT07609862) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2026-07-14 |
| A Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL (NCT07609823) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2026-07-14 |
| A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (NCT07570017) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2026-05-30 |
| A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutinib Tablet (NCT07374224) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2026-03-05 |
| A Study of Rocbrutinib Versus Investigator's Choice of BTK Inhibitors in Patients With Relapsed or Refractory Mantle Cell Lymphoma (NCT07377578) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2026-02-05 |
| A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma (NCT07189065) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2025-11-27 |
| Phase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed B-cell Non-Hodgkin Lymphoma (NCT06251180) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2024-04-10 |
| The Mass Balance Study of LP-168 in Healthy Subjects (NCT06126861) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2023-12-25 |
| A Food Effect Study of LP-168 Tablets in Healthy Subjects (NCT05917964) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2023-06-21 |
| A Study of Rocbrutinib in Participants With Relapse or Refractory Mantle Cell Lymphoma (NCT05716087) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2023-02-21 |
| A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML (NCT05641259) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2023-02-14 |
| A Study of LP-168 in Healthy Volunteers (NCT05432713) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2022-05-14 |
| A Study of LP-128 Capsules in Healthy Subjects (NCT05130567) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2021-11-19 |
| A Study of LP-118 in Patients With Advanced Tumors (NCT05025358) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2021-09-08 |
| A Study of LP-168 in Participants With Relapse or Refractory B-Cell Lymphoma (NCT04993690) | Guangzhou Lupeng Pharmaceutical Company LTD. | 2021-07-06 |